Close

FibroGen Announces FDA Advisory Committee to Review Roxadustat New Drug Application Tentatively Scheduled for July 15, 2021

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BSX
8. PI
9. NOW
10. CNMD


Go back to FibroGen Announces FDA Advisory Committee to Review Roxadustat New Drug Application Tentatively Scheduled for July 15, 2021
(NASDAQ: FGEN) Delayed: 0.98 --0 (-0%)
Previous Close $0.98    52 Week High $31.90 
Open $0.95    52 Week Low $14.38 
Day High $0.99    P/E N/A 
Day Low $0.90    EPS $0.00 
Volume 512,667